- Home
- Search Results
Search Results
Filter :
FILTER BY keyword:
- diabetes [5]
- COVID-19 [2]
- ICU [1]
- Mucormycosis [1]
- Qatar [1]
- SGLT-inhibitors [1]
- adolescents [1]
- cavernous sinus thrombosis [1]
- cranial nerve palsies [1]
- death [1]
- diabetes type 2 [1]
- empagliflozin [1]
- euglycemic diabetic ketoacidosis [1]
- invasive ventilation [1]
- obesity [1]
- primary health care [1]
- teleconsultations [1]
- youth [1]
- [+] More [-] Less
FILTER BY author:
- Ahmad Rimawi [1]
- Ahmad Saadeh [1]
- Amin Shehadeh [1]
- Ashraf Elmalik [1]
- Fatemeh Ahmadi [1]
- Ghadeer Daghash [1]
- Hajieh Bibi Shahbazian [1]
- Hamzeh Alsaleh [1]
- Katie Nahas [1]
- Kerry Wilbur [1]
- Mariama Mansaray [1]
- Maryam Shaabanpour Fooladi [1]
- Mehrdad Dargahi-Malamir [1]
- Mehrnoosh Zakerkish [1]
- Mohamed Fahed Faleh [1]
- Mohammad Nour Chabalout [1]
- Mohammed Yahya Alsaleh [1]
- Mouna Al Saad [1]
- Muhammad Shuaib Afzal [1]
- Rawan Salameh [1]
- Reem Alfawares [1]
- Sahar Selmi [1]
- Samya Ahmad Al-Abdulla [1]
- Seyed Peyman Payami [1]
- Sharoud Mathis [1]
- [+] More [-] Less
FILTER BY language:
FILTER BY content type:
FILTER BY publication:
FILTER BY affiliation:
- 1Undergraduate Pharmacy Graduates, College of Pharmacy, Qatar University, Doha, Qatar [1]
- 2Qatar Diabetes Association, Doha, Qatar [1]
- 3Associate Professor and Director, Doctor of Pharmacy Program, College of Pharmacy, Qatar University, Doha, Qatar [1]
- Department of Infectious Diseases, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran [1]
- Department of Internal Medicine, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran [1]
- Department of Special Surgery, School of Medicine, University of Jordan, Amman, Jordan E-mail: [email protected] [1]
- Diabetes research center, Health research institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran E-mail: [email protected] [1]
- Emergency Department, Hamad Medical Corporation, Doha, Qatar Email: [email protected] [1]
- Primary Health Care Corporation Doha, Qatar E-mail: [email protected] [1]
- Primary Health Care Corporation, Doha, Qatar [1]
- School of Medicine, University of Jordan, Amman, Jordan [1]
- [+] More [-] Less
FILTER BY article type:
FILTER BY access type:
A program for obese youth at-risk for diabetes in Qatar
Background: Obesity is an international public health problem well documented in Qatar among children and adolescents and contributes to diabetes a disease already highly prevalent in the country. We describe an intervention program developed for obese youth conducted by the Qatar Diabetes Association (QDA). Methods: The QDA conducts a 3-day structured program for obese youth at-risk for developing diabetes which includes physical activities games and workshops aimed to increase awareness and guide improved diet activity and related lifestyle choices. Using motivational interviewing techniques obese youth develop action plans to modify diet and exercise which were shared with parents to promote collaboration and support. Results: In 2011 one girls' camp (n = 15 mean age 12 years) and one boys' camp (n = 17 mean age 13 years) were held. All participants were considered obese: girls mean BMI = 31 kg/m2 (standard deviation (SD) 4.2) and boys mean BMI 35 kg/m2 (SD = 4.7). Youth reported fast food consumption at least twice a week by 6 (40 %) of girls and 10 (59 %) of boys and there was low self-declared frequency of daily physical activity (1 girl and 5 boys). Many stated their weight made their life worse due to fatigue poor agility or difficulty finding clothes. When individualized coaching was proposed 87 % and 100 % of girls and boys felt ready to devise an action plan for improved health. Conclusion: The new national preventative healthcare mandate could facilitate modification and expansion of these QDA educational and behavioural intervention programs as part of the wider strategy to combat obesity in Qatar.
Improving clinical outcomes for type 2 diabetes patients using teleconsultations during the COVID-19 pandemic
Background: Diabetic patients are at significant risk of serious complications and higher mortality rates if they contract COVID-19123. Primary Health Care Corporation (PHCC) in Qatar launched a Diabetes Teleconsultation Clinic to proactively support high risk diabetic patients with a hemoglobin A1c (HbA1C) superior or equal to 8 mg/dL and without a primary health care encounter in the last 2-12 months in an attempt to support this high risk population and still provide continuity of care. Methods/Case presentation: Patients meeting the criteria were proactively contacted and received a teleconsultation call from a family medicine physician. During the call family physicians and patients reviewed individual management plans and if agreed and required changes the patient management plans were adjusted and monitored. Patients were additionally supported by a wider team of professionals via teleconsultations including dieticians health educators and primary care psychology and psychiatry services. A paired sample T-Test (Table 1) was conducted to compare the HbA1c mean levels for patients before and after joining the PHCC Diabetes Management Teleconsultation Clinic after a 4-month period. Results/Findings/Recommendations: There was a statistically significant difference in the results of mean HbA1c levels for patients before joining the Diabetes Management Teleconsultation Clinic and after the intervention. Of the 384 patients analysed the average HbA1c level before the intervention was 9.49 mg/dL and after the intervention the average was 8.83 mg/dL (p < 0.001). Conclusion: The use of teleconsultations remote multidisciplinary team support and collaborative patient management plans has had a positive impact on the health outcomes of 384 high-risk diabetic patients within primary care. This inclusive model of care will be replicated to support more patients as a preventative and supportive intervention not only during the COVID-19 pandemic but in the long term.
Mucormycosis with extensive cranial nerve involvement as the first presentation of diabetes mellitus: A case report
Mucormycosis a rare fungal infection mainly affects individuals with diabetes mellitus and those who were immunocompromised and has a high mortality rate. Its most common presentation is similar to that of acute bacterial sinusitis with symptoms of nasal congestion headache and fever. The involvement of multiple cranial nerves in mucormycosis was rarely reported in the literature and indicates severe disease. Herein we report the case of a 56-year-old man who was referred to the ophthalmology outpatient clinic for facial nerve palsy. He was treated with systemic steroids for 10 days with no improvement. On examination he had a loss of vision and a frozen orbit due to involvement of cranial nerves II III IV V VI and VII. An extensive workup revealed a hemoglobin A1C of 10%. However he was never diagnosed with diabetes mellitus previously and denied any of the classical symptoms of diabetes mellitus. He underwent ethmoidectomy maxillectomy and drainage of an intraorbital abscess after appropriate imaging studies. Histopathology confirmed the diagnosis of mucormycosis and the patient was started on systemic amphotericin B. This case emphasizes the importance of screening for diabetes mellitus. Early recognition of underlying diabetes mellitus in this patient may have prevented the development of mucormycosis along with its devastating complications.
Assessment of Mortality Rate, Need for ICU Admission and Ventilation in COVID-19 Patients with Diabetes Mellitus
Introduction: Coronavirus disease 2019 (COVID-19) has become a threat to public health. People with chronic diseases such as diabetes are at a greater risk of severe diseases and death upon contracting this new disease. Due to the novelty of COVID-19 no specific information is available about the degree of its mortality and risk factors among diabetic patients. Therefore this study aims to compare diabetic and nondiabetic COVID-19 patients regarding mortality rate the need for intensive care unit (ICU) admission invasive and noninvasive ventilation and the associated risk factors.
Methods: This was a cross-sectional study performed on the medical records of 650 adult COVID-19 patients (325 diabetics and 325 nondiabetics) admitted to Razi Hospital in Ahvaz from March 2020 to September 2020.
Results: The mean age of the patients was 61.3 years in the diabetic group and 52.3 years in the nondiabetic group. Men comprised 48.3% of the diabetic group and 59.7% of the nondiabetic group. Diabetic patients suffered from significantly more underlying diseases such as ischemic heart disease (IHD) hypertension (HTN) chronic kidney disease (CKD) and acute renal failure (ARF) compared to the nondiabetic group (p < 0.0001). Also when compared with the nondiabetic group the diabetic group had a significantly higher mortality rate (17.5% vs. 12%; p = 0.047 respectively) more ICU admissions (35.4% vs. 27.7%; p = 0.035 respectively) and a greater need for invasive ventilation (17.5% vs. 11.4%; p = 0.026 respectively).
Conclusion: In diabetic patients the mortality rate need for ICU admission and need for invasive ventilation were significantly higher than nondiabetic patients. Our logistic regression analysis in diabetic patients with COVID-19 showed that age CKD and ARF were the risk factors affecting mortality. In contrast age and CKD were the risk factors affecting the rate of ICU admission and CKD and ARF were the risk factors affecting the need for invasive ventilation.
Case report of empagliflozin-induced euglycemic diabetic ketoacidosis
Diabetic ketoacidosis (DKA) is a common metabolic emergency in diabetic patients encountered by emergency departments (EDs). Euglycemic diabetic ketoacidosis (EDKA) is a rare type of DKA characterized by normal to slightly elevated blood glucose levels. Possible causes of EDKA include fasting pregnancy and alcohol consumption.
In this report we are presenting a case of EDKA associated with the use of empagliflozin an oral antihyperglycemic medication belonging to the sodium-glucose co-transporter 2 inhibitors (SGLT-2). The case is a 43-year-old diabetic male patient who presented to the ED complaining of nausea vomiting and generalized weakness. Upon history taking it was found that the patient started taking empagliflozin 10 days ago. Accordingly appropriate diagnostic tests were requested and the patient was found to have severe DKA despite normal to slightly elevated blood glucose results. A diagnosis of EDKA was confirmed and the patient was successfully treated and discharged few days later.
Many reports have linked the use of SGLT-2 inhibitors with an increased risk of developing DKA especially EDKA. Although the management of DKA and EDKA is similar it is more challenging to diagnose the latter. We have highlighted these challenges and the most common precipitating factors. Additionally we highlighted the mechanism for developing EDKA and the appropriate diagnostic approach to follow with diabetic patients using SGLT-2 inhibitors.